Transcatheter embolization is a method of insertion synthetic material or medication called embolic agent into blood vessel during catheter to block the blood flow in the direction of a specific area of the body. Embolization is a very efficient method to prevent anomalous bleeding and is simply enveloping as compared to open surgery. The transcatheter embolization and occlusion devices market have observed physically powerful development in the past few years because of the increasing focus on improvement, resulting in superior product approvals and product launches around the word. The market is also differentiating by considerable research and progress leading to numerous technological innovations.
How Big is the Transcatheter Embolization and Occlusion Devices Market?
The Transcatheter Embolization and Occlusion Devices market is expected to be around US$ 5.60 Billion by 2028; Growing at a CAGR of more than 7.5% in the given forecast period.
The major driving factors of Transcatheter Embolization & Occlusion devices market are as follows:
• Increasing prevalence of cancer
• Rising approval of minimally invasive surgeries
The restraining factors of Transcatheter Embolization and Occlusion devices market are as follows:
• High rate of the products.
• Need of skilled professionals
The transcatheter embolization and occlusion devices market is segmented on the lines of its product, end user, application and regional. Product is further segmented into accessories, embolization particles, embolization coils, liquid embolics and flow diverter devices. Accessories consist of catheters, guidewires and others. Under embolization particles segmentation it covers drug eluting beads, microspheres, radio embolization particles and others. Under embolization coils segmentation it covers balloon assisted coiling, stent assisted coiling, coiling assist devices, detachable and pushable. Based on end user segmentation it covers hospitals, ambulatory surgical centers and clinics. Based on application segmentation it covers peripheral vascular disease, neurology, oncology, urology and others. The transcatheter embolization and occlusion devices market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for transcatheter embolization and occlusion devices and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for transcatheter embolization and occlusion devices.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Transcatheter Embolization and Occlusion Devices Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include St. Jude Medical, Inc., Abbott Laboratories,Medtronic plc, BTG plc, Boston Scientific Corporation, Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Merit Medical Systems, Inc., Penumbra, Inc., Pfizer, Inc., Sirtex Medical Limited, Stryker Corporation, and Terumo Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Transcatheter Embolization & Occlusion Devices Market has been segmented as below:
By Product Segment Analysis
• Accessories
o Catheters
o Guidewires
o Others
• Embolization particles
o Drug eluting beads
o Microspheres
o Radioembolization particles
o Others
• Embolization coils
o Balloon assisted coiling
o Stent assisted coiling
o Coiling assist devices
o Detachable
o Pushable
• Liquid embolics
• Flow diverter devices
By End-user Analysis
• Hospitals
• Ambulatory Surgical Centers
• Clinics
By Application Analysis
• Peripheral Vascular Disease
• Neurology
• Oncology
• Urology
• Others
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all transcatheter embolization and occlusion devices.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of transcatheter embolization and occlusion devices data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Dental Diagnostic & Surgical Equipment Market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2. Assumptions and Research Methodology
3. Executive Summary: Transcatheter Embolization and Occlusion Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Market Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, 2022–2027
4.4.1. Market Volume Projections, 2022–2027 (Units)
4.4.2. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
4.6. Value Chain Analysis
4.7. Market Outlook
5. Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, by Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.2. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product Type, 2022–2027
5.2.1. Embolization Coils
5.2.1.1. Pushable
5.2.1.2. Detachable
5.2.2. Coiling Assist Devices
5.2.2.1. Stent Assist
5.2.2.2. Balloon Assist
5.2.3. Embolization Particles
5.2.3.1. Radioembolization Spheres
5.2.3.2. Microspheres
5.2.3.3. Drug eluting Beads
5.2.3.4. Others
5.2.4. Flow Diverting Devices
5.2.5. Liquid Embolics Accessories
5.2.5.1. Catheters
5.2.5.2. Guidewires
5.2.5.3. Others
5.3. Market Attractiveness, by Product Type, 2015
6. Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, by Application, 2016–2024
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Application, 2022–2027
6.4.1. Peripheral Vascular Disease
6.4.2. Neurology
6.4.3. Oncology
6.4.4. Urology
6.4.5. Others
6.5. Market Attractiveness, by Application, 2015
7. Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, by End-user, 2016–2024
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Key Trends
7.4. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by End-user, 2022–2027
7.4.1. Hospitals
7.4.2. Ambulatory Centers
7.4.3. Clinics
7.5. Market Attractiveness, by End-user, 2015
8. Transcatheter Embolization and Occlusion Devices Market Analysis and Forecasts, by Region, 2016–2024
8.1. Key Findings
8.2. Policies and Regulations
8.3. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Region, 2022–2027
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa
8.4. Market Attractiveness, by Country/Region, 2022
9. North America Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, 2015–2025
9.1. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product
9.1.1. Embolization Coils
9.1.1.1. Pushable
9.1.1.2. Detachable
9.1.2. Coiling Assist Devices
9.1.2.1. Stent Assist
9.1.2.2. Balloon Assist
9.1.3. Embolization Particles
9.1.3.1. Radioembolization Spheres
9.1.3.2. Microspheres
9.1.3.3. Drug eluting Beads
9.1.3.4. Others
9.1.4. Flow Diverting Devices
9.1.5. Liquid Embolics Accessories
9.1.5.1. Catheters
9.1.5.2. Guidewires
9.1.5.3. Others
9.2. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Application
9.2.1. Peripheral Vascular Disease
9.2.2. Neurology
9.2.3. Oncology
9.2.4. Urology
9.2.5. Others
9.3. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by End-user
9.3.1. Hospitals
9.3.2. Ambulatory Centers
9.3.3. Clinics
9.4. North America Market, by Country, (US$), 2022–2027
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness, by Country, 2022
9.6. Market Attractiveness, by Product type, 2022
9.7. Market Attractiveness, by Application, 2022
9.8. Market Attractiveness, by End-user, 2022
10. Europe Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast
10.1. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product
10.1.1. Embolization Coils
10.1.1.1. Pushable
10.1.1.2. Detachable
10.1.2. Coiling Assist Devices
10.1.2.1. Stent Assist
10.1.2.2. Balloon Assist
10.1.3. Embolization Particles
10.1.3.1. Radioembolization Spheres
10.1.3.2. Microspheres
10.1.3.3. Drug eluting Beads
10.1.3.4. Others
10.1.4. Flow Diverting Devices
10.1.5. Liquid Embolics Accessories
10.1.5.1. Catheters
10.1.5.2. Guidewires
10.1.5.3. Others
10.2. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Application
10.2.1. Peripheral Vascular Disease
10.2.2. Neurology
10.2.3. Oncology
10.2.4. Urology
10.2.5. Others
10.3. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by End-user
10.3.1. Hospitals
10.3.2. Ambulatory Centers
10.3.3. Clinics
10.4. Europe Market, by Country, (US$), 2022–2027
10.4.1. U.K.
10.4.2. Germany
10.4.3. Rest of Europe
10.5. Market Attractiveness, by Country, 2022
10.6. Market Attractiveness, by Product type, 2022
10.7. Market Attractiveness, by Application, 2022
10.8. Market Attractiveness, by End-user, 2022
11. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, 2022–20227
11.1. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product
11.1.1. Embolization Coils
11.1.1.1. Pushable
11.1.1.2. Detachable
11.1.2. Coiling Assist Devices
11.1.2.1. Stent Assist
11.1.2.2. Balloon Assist
11.1.3. Embolization Particles
11.1.3.1. Radioembolization Spheres
11.1.3.2. Microspheres
11.1.3.3. Drug eluting Beads
11.1.3.4. Others
11.1.4. Flow Diverting Devices
11.1.5. Liquid Embolics Accessories
11.1.5.1. Catheters
11.1.5.2. Guidewires
11.1.5.3. Others
11.2. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Application
11.2.1. Peripheral Vascular Disease
11.2.2. Neurology
11.2.3. Oncology
11.2.4. Urology
11.2.5. Others
11.3. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by End-user
11.3.1. Hospitals
11.3.2. Ambulatory Centers
11.3.3. Clinics
11.4. Asia Pacific Market, by Country, (US$), 2015–2025
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia
11.4.5. Rest of APAC
11.5. Market Attractiveness, by Country, 2022
11.6. Market Attractiveness, by Product type, 2022
11.7. Market Attractiveness, by Application, 2022
11.8. Market Attractiveness, by End-user, 2022
12. Latin America Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, 2022–2027
12.1. Market Size (US$ Mn) and Volume (No. of Units) Forecast by Product
12.1.1. Embolization Coils
12.1.1.1. Pushable
12.1.1.2. Detachable
12.1.2. Coiling Assist Devices
12.1.2.1. Stent Assist
12.1.2.2. Balloon Assist
12.1.3. Embolization Particles
12.1.3.1. Radioembolization Spheres
12.1.3.2. Microspheres
12.1.3.3. Drug eluting Beads
12.1.3.4. Others
12.1.4. Flow Diverting Devices
12.1.5. Liquid Embolics Accessories
12.1.5.1. Catheters
12.1.5.2. Guidewires
12.1.5.3. Others
12.2. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Application
12.2.1. Peripheral Vascular Disease
12.2.2. Neurology
12.2.3. Oncology
12.2.4. Urology
12.2.5. Others
12.3. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by End-user
12.3.1. Hospitals
12.3.2. Ambulatory Centers
12.3.3. Clinics
12.4. Latin America Market, by Country, (US$), 2015–2025
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of LATAM
12.5. Market Attractiveness, by Country, 2015
12.6. Market Attractiveness, by Product type, 2015
12.7. Market Attractiveness, by Application, 2015
12.8. Market Attractiveness, by End-user, 2015
13. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, 2022–2027
13.1. Market Size (US$ Mn) and Volume (No. of Units) Forecast by Product
13.1.1. Embolization Coils
13.1.1.1. Pushable
13.1.1.2. Detachable
13.1.2. Coiling Assist Devices
13.1.2.1. Stent Assist
13.1.2.2. Balloon Assist
13.1.3. Embolization Particles
13.1.3.1. Radioembolization Spheres
13.1.3.2. Microspheres
13.1.3.3. Drug eluting Beads
13.1.3.4. Others
13.1.4. Flow Diverting Devices
13.1.5. Liquid Embolics Accessories
13.1.5.1. Catheters
13.1.5.2. Guidewires
13.1.5.3. Others
13.2. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Application
13.2.1. Peripheral Vascular Disease
13.2.2. Neurology
13.2.3. Oncology
13.2.4. Urology
13.2.5. Others
13.3. Market Size (US$ Mn) and Volume (No. of Units) Forecast, by End-user
13.3.1. Hospitals
13.3.2. Ambulatory Centers
13.3.3. Clinics
13.4. Middle East & Africa Market, by Country, (US$), 2015–2025
13.4.1. UAE
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
14. Competition Landscape
14.1. Market Player – Competition Matrix (by Tier and Size of companies)
14.2. Market Share Analysis, by Company (2015)
14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.3.1. Abbott Laboratories
14.3.1.1. Company Details
14.3.1.2. Company Description
14.3.1.3. Business Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Financials
14.3.1.6. Strategic Overview
14.3.1.7. Product Portfolio
14.3.1.8. Recent Developments
14.3.2. Boston Scientific Corporation
14.3.2.1. Company Details
14.3.2.2. Company Description
14.3.2.3. Business Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Financials
14.3.2.6. Strategic Overview
14.3.2.7. Product Portfolio
14.3.2.8. Recent Developments
14.3.3. BTG International Ltd
14.3.3.1. Company Details
14.3.3.2. Company Description
14.3.3.3. Business Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Financials
14.3.3.6. Strategic Overview
14.3.3.7. Product Portfolio
14.3.3.8. Recent Developments
14.3.4. Cook Medical
14.3.4.1. Company Details
14.3.4.2. Company Description
14.3.4.3. Business Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Financials
14.3.4.6. Strategic Overview
14.3.4.7. Product Portfolio
14.3.4.8. Recent Developments
14.3.5. Edward Lifesciences
14.3.5.1. Company Details
14.3.5.2. Company Description
14.3.5.3. Business Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Financials
14.3.5.6. Strategic Overview
14.3.5.7. Product Portfolio
14.3.5.8. Recent Developments
14.3.6. Johnson & Johnson
14.3.6.1. Company Details
14.3.6.2. Company Description
14.3.6.3. Business Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Financials
14.3.6.6. Strategic Overview
14.3.6.7. Product Portfolio
14.3.6.8. Recent Developments
14.3.7. Medtronic, plc
14.3.7.1. Company Details
14.3.7.2. Company Description
14.3.7.3. Business Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Financials
14.3.7.6. Strategic Overview
14.3.7.7. Product Portfolio
14.3.7.8. Recent Developments
14.3.8. Merit Medical Systems, Inc.
14.3.8.1. Company Details
14.3.8.2. Company Description
14.3.8.3. Business Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Financials
14.3.8.6. Strategic Overview
14.3.8.7. Product Portfolio
14.3.8.8. Recent Developments
14.3.9. Penumbra, Inc.
14.3.9.1. Company Details
14.3.9.2. Company Description
14.3.9.3. Business Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Financials
14.3.9.6. Strategic Overview
14.3.9.7. Product
14.3.9.8. Recent Developments
14.3.10. Pfizer, Inc.
14.3.10.1. Company Details
14.3.10.2. Company Description
14.3.10.3. Business Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Financials
14.3.10.6. Strategic Overview
14.3.10.7. Product Portfolio
14.3.10.8. Recent Developments
14.3.11. Sirtex Medical Limited
14.3.11.1. Company Details
14.3.11.2. Company Description
14.3.11.3. Business Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Financials
14.3.11.6. Strategic Overview
14.3.11.7. Product Portfolio
14.3.11.8. Recent Developments
14.3.12. St. Jude Medical, Inc.
14.3.12.1. Company Details
14.3.12.2. Company Description
14.3.12.3. Business Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Financials
14.3.12.6. Strategic Overview
14.3.12.7. Product Portfolio
14.3.12.8. Recent Developments
14.3.13. Stryker Corporation
14.3.13.1. Company Details
14.3.13.2. Company Description
14.3.13.3. Business Overview
14.3.13.4. SWOT Analysis
14.3.13.5. Financials
14.3.13.6. Strategic Overview
14.3.13.7. Product Portfolio
14.3.13.8. Recent Developments
14.3.14. Terumo Corporation
14.3.14.1. Company Details
14.3.14.2. Company Description
14.3.14.3. Business Overview
14.3.14.4. SWOT Analysis
14.3.14.5. Financials
14.3.14.6. Strategic Overview
14.3.14.7. Product Portfolio
14.3.14.8. Recent Developments
The Transcatheter Embolization & Occlusion Devices Market has been segmented as below:
By Product Segment Analysis
• Accessories
o Catheters
o Guidewires
o Others
• Embolization particles
o Drug eluting beads
o Microspheres
o Radioembolization particles
o Others
• Embolization coils
o Balloon assisted coiling
o Stent assisted coiling
o Coiling assist devices
o Detachable
o Pushable
• Liquid embolics
• Flow diverter devices
By End-user Analysis
• Hospitals
• Ambulatory Surgical Centers
• Clinics
By Application Analysis
• Peripheral Vascular Disease
• Neurology
• Oncology
• Urology
• Others
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
